Jupiter Medical Center is among the first hospitals in South Florida to offer Zulresso™, a treatment for postpartum depression (PPD). Developed by Sage Therapeutics, Zulresso is the first and only medicine specifically approved to treat PPD, the most common medical complication of childbirth.
The typical treatment for postpartum depression includes a prescription of antidepressants and/or psychotherapy, with patients recovering within two to four weeks. Zulresso is delivered via continuous IV over 60 hours (2.5 days), offering the potential for the rapid treatment of depressive symptoms of PPD.
“Jupiter Medical Center remains on the cutting edge of providing safe, high quality patient care using state-of-the-art technology and advanced treatment options,” said Joanne Miller, interim co-CEO. “We are especially proud to be among the first in our community to provide this much-needed care for new mothers at this very delicate time.”
“This a major breakthrough in the treatment of postpartum depression,” said Dr. Dudley Brown, chief of Obstetrics and Gynecology at Jupiter Medical Center. “Zulresso works so quickly that patients can see improvement in their symptoms within days—instead of weeks. This will result in them feeling like themselves more quickly which will be beneficial for them, their newborn and their family.”
Approved by the U.S. Food & Drug Administration in March of this year, Zulresso must be administered in health care facilities certified under the Zulresso Risk Evaluation and Mitigation Strategy (REMS) program due to potential side effects during treatment. Throughout their IV process, patients are under observation for excessive sedation and sudden loss of consciousness, as well as continuous monitoring of their blood oxygen level.
